Senestech (SNES) Set to Post Quarterly Earnings on Monday

Senestech (NASDAQ:SNES) is anticipated to release its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect Senestech to announce earnings of ($0.31) per share and revenue of $0.92 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Monday, November 9, 2026 at 5:00 PM ET.

Senestech (NASDAQ:SNES) last announced its quarterly earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share for the quarter, topping the consensus estimate of ($0.37) by $0.02. The firm had revenue of $0.77 million during the quarter, compared to analysts’ expectations of $0.60 million. Senestech had a negative net margin of 294.73% and a negative return on equity of 71.89%. On average, analysts expect Senestech to post ($1.27) EPS for the current fiscal year and ($1.07) EPS for the next fiscal year.

Senestech Price Performance

Shares of NASDAQ SNES opened at $1.08 on Monday. Senestech has a 12-month low of $0.55 and a 12-month high of $3.61. The stock’s fifty day simple moving average is $0.85 and its two-hundred day simple moving average is $1.49. The stock has a market capitalization of $5.86 million, a PE ratio of -0.79 and a beta of 0.25. The company has a current ratio of 6.78, a quick ratio of 5.81 and a debt-to-equity ratio of 0.02.

Analyst Ratings Changes

Separately, Weiss Ratings lowered shares of Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, August 11th. One analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock presently has an average rating of “Sell”.

Insider Activity at Senestech

In other news, major shareholder Glenbrook Capital Management bought 28,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 28th. The shares were purchased at an average price of $0.97 per share, for a total transaction of $27,160.00. Following the completion of the transaction, the insider directly owned 2,194,973 shares in the company, valued at approximately $2,129,123.81. This represents a 1.29% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders bought a total of 1,145,169 shares of company stock worth $842,773 over the last three months. Insiders own 2.20% of the company’s stock.

About Senestech

SenesTech, Inc is a biotechnology company focused on developing fertility-control technologies for managing animal populations. The company’s approach is designed to reduce reproduction rather than rely solely on lethal control methods, with applications primarily in rodent management.

SenesTech’s principal product is ContraPest, a liquid bait designed to reduce fertility in rats by affecting reproductive function in both male and female animals. The product is intended for use in commercial, municipal and other settings where rat populations pose sanitation, health or property risks.